{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:23Z","timestamp":1792787303642,"version":"4.5.0"},"reference-count":44,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Programme Hospitalier de Recherche Clinique","award":["FTLD-exome"],"award-info":[{"award-number":["FTLD-exome"]}]},{"name":"Programme Hospitalier de Recherche Clinique","award":["Predict-PGRN"],"award-info":[{"award-number":["Predict-PGRN"]}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-PRTS PREV-DEMALS"],"award-info":[{"award-number":["ANR-PRTS PREV-DEMALS"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["\u201cInvestissements d\u2019avenir\u201d ANR-11-INBS-0011"],"award-info":[{"award-number":["\u201cInvestissements d\u2019avenir\u201d ANR-11-INBS-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014808","name":"Fondation Vaincre Alzheimer","doi-asserted-by":"publisher","award":["FR-17035"],"award-info":[{"award-number":["FR-17035"]}],"id":[{"id":"10.13039\/100014808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Neurofilament light chain (NfL) is a promising biomarker in genetic frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). We evaluated plasma neurofilament light chain (pNfL) levels in controls, and their longitudinal trajectories in\n                      <jats:italic>C9orf72<\/jats:italic>\n                      and\n                      <jats:italic>GRN<\/jats:italic>\n                      cohorts from presymptomatic to clinical stages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analysed pNfL using Single Molecule Array (SiMoA) in 668 samples (352 baseline and 316 follow-up) of\n                      <jats:italic>C9orf72<\/jats:italic>\n                      and\n                      <jats:italic>GRN<\/jats:italic>\n                      patients, presymptomatic carriers (PS) and controls aged between 21 and 83. They were longitudinally evaluated over a period of &gt;2\u2009years, during which four PS became prodromal\/symptomatic. Associations between pNfL and clinical\u2013genetic variables, and longitudinal NfL changes, were investigated using generalised and linear mixed-effects models. Optimal cut-offs were determined using the Youden Index.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      pNfL levels increased with age in controls, from ~5\u2009to~18\u2009pg\/mL (p&lt;0.0001), progressing over time (mean annualised rate of change (ARC): +3.9%\/year, p&lt;0.0001). Patients displayed higher levels and greater longitudinal progression (ARC: +26.7%, p&lt;0.0001), with gene-specific trajectories.\n                      <jats:italic>GRN<\/jats:italic>\n                      patients had higher levels than\n                      <jats:italic>C9orf72<\/jats:italic>\n                      (86.21 vs 39.49\u2009pg\/mL, p=0.014), and greater progression rates (ARC:+29.3% vs +24.7%; p=0.016). In\n                      <jats:italic>C9orf72<\/jats:italic>\n                      patients, levels were associated with the phenotype (ALS: 71.76\u2009pg\/mL, FTD: 37.16, psychiatric: 15.3; p=0.003) and remarkably lower in slowly progressive patients (24.11, ARC: +2.5%; p=0.05). Mean ARC was +3.2% in PS and +7.3% in prodromal carriers. We proposed gene-specific cut-offs differentiating patients from controls by decades.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the importance of gene-specific and age-specific references for clinical and therapeutic trials in genetic FTD\/ALS. It supports the usefulness of repeating pNfL measurements and considering ARC as a prognostic marker of disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02590276\">NCT02590276<\/jats:ext-link>\n                      and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04014673\">NCT04014673<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2021-326914","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T13:20:46Z","timestamp":1628083246000},"page":"1278-1288","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Plasma NfL levels and longitudinal change rates in\n                    <i>C9orf72<\/i>\n                    and\n                    <i>GRN<\/i>\n                    -associated diseases: from tailored references to clinical applications"],"prefix":"10.1136","volume":"92","clinical-trial-number":[{"clinical-trial-number":"nct02590276","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04014673","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-9743","authenticated-orcid":false,"given":"Dario","family":"Saracino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-3203","authenticated-orcid":false,"given":"Karim","family":"Dorgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Camuzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Rametti-Lacroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Houot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Clot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Martin-Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Jornea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Azuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-8474","authenticated-orcid":false,"given":"Raffaella","family":"Migliaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Couratier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Auriacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Sauv\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Boutoleau-Bretonni\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Didic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Hannequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the French Research Network on FTD\/FTD-ALS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PREV-DEMALS and Predict-PGRN study groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Colliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Forlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-5181","authenticated-orcid":false,"given":"Isabelle","family":"Le Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"2022011011051745000_92.12.1278.1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05016"},{"key":"2022011011051745000_92.12.1278.2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05017"},{"key":"2022011011051745000_92.12.1278.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.011"},{"key":"2022011011051745000_92.12.1278.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.010"},{"key":"2022011011051745000_92.12.1278.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30394-1"},{"key":"2022011011051745000_92.12.1278.6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr355"},{"key":"2022011011051745000_92.12.1278.7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301883"},{"key":"2022011011051745000_92.12.1278.8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-019-0483-2","article-title":"Phenocopy syndrome of behavioral variant frontotemporal dementia: a systematic review","volume":"11","author":"Valente","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"2022011011051745000_92.12.1278.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0058-z"},{"key":"2022011011051745000_92.12.1278.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106"},{"key":"2022011011051745000_92.12.1278.11","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"2022011011051745000_92.12.1278.12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2022011011051745000_92.12.1278.13","doi-asserted-by":"crossref","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","article-title":"Serum neurofilament light chain in behavioral variant frontotemporal dementia","volume":"91","author":"Steinacker","year":"2018","journal-title":"Neurology"},{"key":"2022011011051745000_92.12.1278.14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1474-4422(19)30354-0","article-title":"Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study","volume":"18","author":"van der Ende","year":"2019","journal-title":"Lancet Neurol"},{"key":"2022011011051745000_92.12.1278.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323487"},{"key":"2022011011051745000_92.12.1278.16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/acn3.51041","article-title":"Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis","volume":"7","author":"Cajanus","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2022011011051745000_92.12.1278.17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/21678421.2016.1241279","article-title":"Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: data from the German MND-net","volume":"18","author":"Steinacker","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2022011011051745000_92.12.1278.18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318704"},{"key":"2022011011051745000_92.12.1278.19","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"2022011011051745000_92.12.1278.20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/21678421.2019.1646769","article-title":"Neurofilaments in pre-symptomatic ALS and the impact of genotype","volume":"20","author":"Benatar","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2022011011051745000_92.12.1278.21","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1212\/WNL.0000000000011848","article-title":"Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration","volume":"96","author":"Rojas","year":"2021","journal-title":"Neurology"},{"key":"2022011011051745000_92.12.1278.22","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl288"},{"key":"2022011011051745000_92.12.1278.23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-150270","article-title":"Lateral temporal lobe: an early imaging marker of the presymptomatic GRN disease?","volume":"47","author":"Caroppo","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2022011011051745000_92.12.1278.24","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2017.4266","article-title":"Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years","volume":"75","author":"Bertrand","year":"2018","journal-title":"JAMA Neurol"},{"key":"2022011011051745000_92.12.1278.25","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324647"},{"key":"2022011011051745000_92.12.1278.26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006344"},{"key":"2022011011051745000_92.12.1278.27","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100699"},{"key":"2022011011051745000_92.12.1278.28","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008359","article-title":"Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers","volume":"93","author":"Cammack","year":"2019","journal-title":"Neurology"},{"key":"2022011011051745000_92.12.1278.29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"2022011011051745000_92.12.1278.30","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24552"},{"key":"2022011011051745000_92.12.1278.31","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"2022011011051745000_92.12.1278.32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","article-title":"Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study","volume":"15","author":"Lle\u00f3","year":"2019","journal-title":"Alzheimers Dement"},{"key":"2022011011051745000_92.12.1278.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14612-6"},{"key":"2022011011051745000_92.12.1278.34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21678421.2020.1779300","article-title":"A multi-center study of neurofilament assay reliability and inter-laboratory variability","volume":"21","author":"Gray","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2022011011051745000_92.12.1278.35","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"2022011011051745000_92.12.1278.36","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2014.1316","article-title":"Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin","volume":"71","author":"Caroppo","year":"2014","journal-title":"JAMA Neurol"},{"key":"2022011011051745000_92.12.1278.37","doi-asserted-by":"crossref","unstructured":"Sudre CH , Bocchetta M , Heller C , et al . White matter hyperintensities in progranulin-associated frontotemporal dementia: a longitudinal GENFI study. Neuroimage 2019;24:102077. doi:10.1016\/j.nicl.2019.102077","DOI":"10.1016\/j.nicl.2019.102077"},{"key":"2022011011051745000_92.12.1278.38","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","article-title":"Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis","volume":"90","author":"Feneberg","year":"2018","journal-title":"Neurology"},{"key":"2022011011051745000_92.12.1278.39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J Psychiatr Res"},{"key":"2022011011051745000_92.12.1278.40","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/ene.14247","article-title":"A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders","volume":"27","author":"Fourier","year":"2020","journal-title":"Eur J Neurol"},{"key":"2022011011051745000_92.12.1278.41","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323541"},{"key":"2022011011051745000_92.12.1278.42","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70324-2"},{"key":"2022011011051745000_92.12.1278.43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","article-title":"Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers","volume":"14","author":"Lee","year":"2017","journal-title":"Neuroimage"},{"key":"2022011011051745000_92.12.1278.44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.25748","article-title":"Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers","volume":"88","author":"Le Blanc","year":"2020","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2021-326914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T14:09:34Z","timestamp":1641823774000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2021-326914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,11,16]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/jnnp-2021-326914"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2021-326914","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]}}}